Intriguingly, the concentration of colivelin used in CRC and oesophageal cancer36 in vitro is much higher than that used in neurodegenerative disease, which may reflect that the regulatory mechanism antagonizing JAK/STAT signalling exists in different disease models. This evidence concerns the gene SOAT1 and colorectal carcinoma.